PH9370A - 15a,16a-methylene-4-oestran-17b-ols and pharmaceutical compositions thereof - Google Patents

15a,16a-methylene-4-oestran-17b-ols and pharmaceutical compositions thereof

Info

Publication number
PH9370A
PH9370A PH14330*UA PH14330A PH9370A PH 9370 A PH9370 A PH 9370A PH 14330 A PH14330 A PH 14330A PH 9370 A PH9370 A PH 9370A
Authority
PH
Philippines
Prior art keywords
oestran
ols
methylene
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
PH14330*UA
Inventor
H Steinbeck
W Elger
R Wiechert
Original Assignee
H Steinbeck
W Elger
R Wiechert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Steinbeck, W Elger, R Wiechert filed Critical H Steinbeck
Publication of PH9370A publication Critical patent/PH9370A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH14330*UA 1972-02-11 1973-02-09 15a,16a-methylene-4-oestran-17b-ols and pharmaceutical compositions thereof PH9370A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (en) 1972-02-11 1972-02-11 15?, 16? -Methylene-4-oestrene-17? -ols or acylates, processes for their production and medicaments containing them

Publications (1)

Publication Number Publication Date
PH9370A true PH9370A (en) 1975-10-22

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
PH14330*UA PH9370A (en) 1972-02-11 1973-02-09 15a,16a-methylene-4-oestran-17b-ols and pharmaceutical compositions thereof

Country Status (29)

Country Link
JP (1) JPS5829317B2 (en)
KR (1) KR780000156B1 (en)
AT (1) AT327413B (en)
AU (1) AU467306B2 (en)
BE (1) BE795241A (en)
CA (1) CA997753A (en)
CH (2) CH590883A5 (en)
CS (1) CS193019B2 (en)
DD (1) DD102379A5 (en)
DE (1) DE2207421C3 (en)
DK (1) DK131037B (en)
EG (1) EG10914A (en)
ES (1) ES410933A1 (en)
FI (1) FI52225C (en)
FR (1) FR2181719B1 (en)
GB (1) GB1425636A (en)
GR (1) GR63160B (en)
HU (1) HU165253B (en)
IE (1) IE37266B1 (en)
IL (1) IL41506A (en)
NL (1) NL177217C (en)
NO (2) NO140304C (en)
PH (1) PH9370A (en)
PL (1) PL81084B1 (en)
RO (1) RO73527A (en)
SE (3) SE403781B (en)
SU (1) SU513628A3 (en)
YU (1) YU35035B (en)
ZA (1) ZA73944B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027636A1 (en) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17β-Cyano-18α-homo-19-nor-androst-4-ene derivative, its use and the derivative-containing drug
DE102007027637A1 (en) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17β-cyano-19-nor-androst-4-ene derivative, its use and the derivative-containing drug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (en) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stackable, rectangular, closed plastic transport container for fine-grained bulk goods and liquids

Also Published As

Publication number Publication date
JPS5829317B2 (en) 1983-06-22
CH590883A5 (en) 1977-08-31
SE7514513L (en) 1975-12-22
HU165253B (en) 1974-07-27
GB1425636A (en) 1976-02-18
JPS4886856A (en) 1973-11-15
YU35035B (en) 1980-06-30
FI52225C (en) 1977-07-11
SE7713896L (en) 1977-12-07
CH593995A5 (en) 1977-12-30
DE2207421A1 (en) 1973-08-16
SU513628A3 (en) 1976-05-05
NL177217C (en) 1985-08-16
RO73527A (en) 1982-02-01
BE795241A (en) 1973-08-09
EG10914A (en) 1976-09-30
ZA73944B (en) 1973-11-28
NO140304C (en) 1979-08-08
SE403781B (en) 1978-09-04
CA997753A (en) 1976-09-28
IL41506A0 (en) 1973-04-30
NL7301974A (en) 1973-08-14
NO140304B (en) 1979-04-30
SE409329B (en) 1979-08-13
AU467306B2 (en) 1975-11-27
AT327413B (en) 1976-01-26
DK131037C (en) 1975-10-20
NO782754L (en) 1973-08-14
FI52225B (en) 1977-03-31
DE2207421C3 (en) 1981-05-07
YU24373A (en) 1979-12-31
ES410933A1 (en) 1976-03-01
ATA112473A (en) 1975-04-15
NO143065B (en) 1980-09-01
NL177217B (en) 1985-03-18
GR63160B (en) 1979-09-25
DD102379A5 (en) 1973-12-12
NO143065C (en) 1980-12-10
IL41506A (en) 1976-07-30
KR780000156B1 (en) 1978-05-02
DK131037B (en) 1975-05-20
IE37266B1 (en) 1977-06-08
AU5207673A (en) 1974-08-15
PL81084B1 (en) 1975-08-30
CS193019B2 (en) 1979-09-17
DE2207421B2 (en) 1980-07-24
IE37266L (en) 1973-08-11
FR2181719B1 (en) 1975-11-21
SE426834B (en) 1983-02-14
FR2181719A1 (en) 1973-12-07

Similar Documents

Publication Publication Date Title
IL42430A0 (en) Pyridopyrrolobenzheterocycles,their preparation and pharmaceutical compositions containing them
IL43762A (en) 11,11-alkylidene-steroids their preparation and pharmaceutical compositions containing them
IL43329A0 (en) New dihydropyridine-polyesters,their production and their pharmaceutical compositions containing them
ZA731808B (en) Pharmaceutical compositions
HK41078A (en) Pharmaceutical composition
IL43837A0 (en) New aminophenyl-ethanolamines and corresponding oxazolidines,their preparation and pharmaceutical compositions containing them
IL43001A0 (en) Novel 4-biphenylyl-alcohols,their preparation and pharmaceutical compositions containing them
IL42429A0 (en) 2-alkoxycephalosporins,their preparation and pharmaceutical compositions containing them
IL42933A0 (en) New 2-alkylamino-dihydropyridines,their production and pharmaceutical compositions containing them
IL49286A0 (en) Novel 1-iodo-1-trans-alkenes,their preparation and pharmaceutical compositions containing them
IL43063A0 (en) Novel-ethyl-imidazoles,their production and pharmaceutical compositions containing them
AU5731773A (en) 2-oxo-indoline compounds and pharmaceutical compositions
IL43283A0 (en) Indoloquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL41562A0 (en) Novel morphinan derivatives,their manufacture and pharmaceutical compositions containing them
IL42613A0 (en) Amino-imidazo-and amino-pyrazolo-isoquinolines,their preparation and pharmaceutical compositions containing them
IL42790A0 (en) 4a-aryl-trans-decahydroisoquino-lines,their preparation and pharmaceutical compositions containing them
IL41463A0 (en) Novel benzylpyrimidines,their manufacture and pharmaceutical compositions containing them
ZA731012B (en) Pharmaceutical compositions
IL40747A0 (en) 1-phenyl-3-hydroxy-3-methyl-triazenes,their preparation and pharmaceutical compositions containing them
ZA732439B (en) Pharmaceutical composition
ZA738187B (en) Pharmaceutical composition and preparation thereof
PH9370A (en) 15a,16a-methylene-4-oestran-17b-ols and pharmaceutical compositions thereof
IL42354A0 (en) Anhydrofuranose derivatives,their manufacture and pharmaceutical compositions containing them
IL41294A0 (en) 15-oxasteroids,their manufacture and pharmaceutical compositions containing them
IL42179A0 (en) Cyclopentenoquinolone derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same